medigraphic.com
ISSN 2174-0798 (Print)
Organo oficial de la Asociación Latinoamericana de Odontopediatría (ALOP)

2019, Number 1

<< Back Next >>

Rev Odotopediatr Latinoam 2019; 9 (1)

Diagnosis and comprehensive treatment for patients with Amelogenesis Imperfecta. Case report

López JMC, Szwarc E

Language: Spanish
References: 21
Page: 54-65
PDF size: 723.44 Kb.


ABSTRACT

Amelogenesis Imperfecta is a diverse group of hereditary and heterogeneous enamel defects, due to alterations in the formation of dental enamel in quality and/or quantity. Diagnosis is based on clinical and radiological findings, family history, family tree, and genetic diagnosis when it is possible. It is characterized by a wide range of clinical presentations in both dentitions. This condition has a high impact on children and adolescents, generates a very disadvantageous social performance since aesthetic problems and dysfunction limit their quality of life. Comprehensive care becomes an essential aspect and it demands a close and necessary professional, patient and family interaction, which must be established early and in an interdisciplinary way. Objective: We present a patient with Amelogenesis Imperfecta, 11 years old, with a clinical and radiographic diagnosis of hypoplastic type, based on her family history. The treatment integrated several stages: use of remineralizing agents in order to restore Latinoamericanadental tissues, orthodontics to create space for the eruption of the retained canine (13), and the alignment of upper dental arch, and rehabilitation with composite resins and metal crowns fenestrated in occlusal. Conclusion: The five year follow- up, with a very positive attitude of the patient toward the maintenance of her health, suggests that in adolescence, a healthy smile is important in the development of self-esteem and interpersonal relationships.


REFERENCES

  1. Lee JY, Watt RG, Williams DM, Giannobile WV. A New Definition for Oral Health: Implication for Clinical Practice, Policy and Research. J Dent Res. 2017; 96: 125-127.

  2. FDI´s definition of oral health, October 2016. Recuperado de: http://www.fdiworlddental.org/oral-health/vision-2020/fdis-definition-of-oral-health

  3. Poulter JA , Murillo G, Brookes SJ, Smith CE, Parry DA, Silva S, Kirkham J, Inglehearn CF, Mighell AJ. Deletion of ameloblastin exon 6 is associated with amelogenesis imperfecta. Hum Mol Genet. 2014; 23: 5317-24.

  4. Witkop CJ Jr. Amelogenesis imperfecta, dentinogenesis imperfect and dentin dysplasia revisited: Problems in classification. J Oral Pathol. 1988; 17: 547-53.

  5. Murillo G, Silva S, Mata M, Esquivel MJ. Amelogénesis Imperfecta. Probabilidad genética de expresión en futuras generaciones de familias costarricenses. Odovtos-Int. J. Dental S.C. 2014, 16: 71-86.

  6. Prasad MK, Laouina S, El Aloussi M, Dollfus H, Bloch-Zupan A. Amelogenesis Imperfecta: I Family, 2 Phenotypes and 2 Mutated genes. J Dent Res. 2016; 95: 1457-63.

  7. Smith C, Murillo G, Brookes SJ, Poulter JA, Silva S, Kirkham J, Inglehearn CF, Mighell AJ. Deletion of amelotin exons 3–6 is associated with amelogenesis imperfect. Hum Mol Genet. 2016; 25: 3578–87.

  8. Koruyucu M, Bayram M, Tuna EB, Gencay K, Seymen F. Clinical Findings and long-term managements of patients with amelogenesis imperfecta. Eur J Dent. 2014; 8: 546-52.

  9. Ortega Urzua O, Rodríguez P, Martínez Morales B. Análisis genético-clínico de una familia afectada con una malformación de esmalte dental. Rev Médica Chilena 2015; 133: 1331-40.

  10. Neville BW, Damm DD, Allen CM, Chi AC. Abnormalities of teeth. En: Oral and Maxillofacial Pathology. 4th ed. St. Louis, MO: Elsevier Saunders; 2016: cap 2.

  11. Gadhia K., McDonald S., Arkutu N., Malik K. Amelogénesis imperfecta: an introduction. Br Dent J. 2012; 212: 377-9.

  12. Poulsen S, Gjørup H, Haubek D, Haukali G, Hintze H, Løvschall H, Errboe M. Amelogenesis imperfecta-a systematic literature review of associated dental and oro-facial abnormalities and tact on patients. Acta Odontol Scand. 2008; 66: 193-9.

  13. Coffield K, Phillips C, Brady M, Roberts MW, Strauss RP, Wright JT. The psychosocial impact of development dental defects in people with hereditary amelogenesis imperfecta. J Am Dent Assoc. 2005; 136: 620–30.

  14. Murillo G, Morales F, Gamboa LC, Meza AM, López AC. Impacto emocional y en calidad de vida de individuos afectados por amelogénesis imperfecta. Odovtos-Int. J. Dent. Sc. 2015; 17: 73-85.

  15. Parekh S, Almehateb M, Cunningham S. How do children with amelogénesis imperfect feel about their teeth? Int. J. Paediatr. Dent. 2014; 24: 326–335.

  16. Montero J, Bravo M, Albaladejo A, Hernández LA, Rosel EM. Validation the Oral Impact Profile (OHIP-14sp for adults in Spain. Med Oral Patol Oral Cir Bucal. 2009 1; 14: 44-50.

  17. Lata S, Varghese NO, Varughese JM. Remineralization potential of fl uoride and amorphous calcium phosphate-casein phosphor peptide on enamel lesions: An in vitro comparative evaluation. J Conserv Dent. 2010; 13: 42-6.

  18. Huq NL, Myroforidis H, Cross KJ, Stanton DP, Veith PD, Ward BR, Reynolds EC. The Interactions of CPP–ACP with Saliva. Int J Mol Sci. 2016 9; 17: 915.

  19. Azarpazhooh A, Limeback H. Clinical efficacy of casein derivatives: A systematic review of the literature. J Am Dent Assoc. 2008; 139: 915-24.

  20. Reynolds EC, Cai F, Cochrane NJ, Shen P, Walker GD, Morgan MV. Fluoride and casein phosphopeptide-amorphous calciumphosphate. J Dent Res. 2008; 87: 344-8

  21. Markovic D, Petrovic B, Peric T. Case series: Clinical findings and oral rehabilitation of patients with amelogenesis imperfecta. Eur Arch Paediatr Dent. 2010; 11: 201-8.




2020     |     www.medigraphic.com